168 related articles for article (PubMed ID: 332438)
1. Comparison of trimazosin and methyldopa in hypertension.
Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
[TBL] [Abstract][Full Text] [Related]
2. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
Aronow WS; Greenfield RS; Alimadadian H; Danahy DT
Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867
[TBL] [Abstract][Full Text] [Related]
3. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
[No Abstract] [Full Text] [Related]
4. Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension.
Verhiest W; Croonenberghs J; Devos P; Fagard R; Amery A
Acta Cardiol; 1974; 29(3):217-33. PubMed ID: 4601854
[No Abstract] [Full Text] [Related]
5. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide.
Moyer RR
Am Heart J; 1983 Nov; 106(5 Pt 2):1250-3. PubMed ID: 6356853
[TBL] [Abstract][Full Text] [Related]
6. Double-blind studies of the clinical effectiveness of prazosin.
Schnaper HW; Oberman A
Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
Aronow WS; Danahy DT
Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
[TBL] [Abstract][Full Text] [Related]
8. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
Winer N; Carter CH; Eddy H
Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
[TBL] [Abstract][Full Text] [Related]
9. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
Oberman A; Pool PE
Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
[TBL] [Abstract][Full Text] [Related]
10. Effect of trimazosin on hemodynamics in chronic heart failure.
Orlando JR; Danahy DT; Lurie M; Aronow WS
Clin Pharmacol Ther; 1978 Nov; 24(5):531-6. PubMed ID: 359215
[TBL] [Abstract][Full Text] [Related]
11. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
Avigdor L; Waeber B; Brunner HR
Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
[TBL] [Abstract][Full Text] [Related]
13. A three-phase clinical evaluation of prazosin.
Smith IS; Fernandes M; Kim KE; Swartz C; Onesti G
Postgrad Med; 1975 Nov; Spec No():53-60. PubMed ID: 1105485
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
Bergstrand RH; Vedin JA; Wilhelmsson CE; Berglund G
Eur J Clin Pharmacol; 1976; 10(6):375-9. PubMed ID: 793848
[TBL] [Abstract][Full Text] [Related]
15. Profile of trimazosin: an effective and safe antihypertensive agent.
Taylor CR; Leader JP; Singleton W; Munster EW; Falkner FC; O'Neil JA
Am Heart J; 1983 Nov; 106(5 Pt 2):1269-81. PubMed ID: 6227228
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
Barritt DW; Marshall AJ; Heaton S
Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
[TBL] [Abstract][Full Text] [Related]
18. Prazosin in hypertension with and without methyldopa.
Kochar MS; Zeller JR; Itskovitz HD
Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
20. Comparison of indoramin and methyldopa in hypertension.
Rosendorff C
S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
